---
stable_id: R-HSA-1225978
display_name: Covalent tyrosine kinase inhibitors bind and inhibit wild-type EGF:EGFR
  dimers
species: Homo sapiens
summary: Covalent (irreversible) TKIs, pelitinib, WZ4002, HKI-272, canertinib and
  afatinib, inhibit the wild-type EGFR through formation of the covalent bond with
  the cysteine residue C397.
---

# Covalent tyrosine kinase inhibitors bind and inhibit wild-type EGF:EGFR dimers
**Reactome ID:** [R-HSA-1225978](https://reactome.org/content/detail/R-HSA-1225978)
**Species:** Homo sapiens

## Summary

Covalent (irreversible) TKIs, pelitinib, WZ4002, HKI-272, canertinib and afatinib, inhibit the wild-type EGFR through formation of the covalent bond with the cysteine residue C397.
